We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00611078
First Posted: February 8, 2008
Last Update Posted: January 20, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Memorial Sloan Kettering Cancer Center
January 25, 2008
February 8, 2008
January 20, 2011
September 2004
January 2011   (Final data collection date for primary outcome measure)
enrollment of 60 participants [ Time Frame: Conclusion of the study ]
Same as current
Complete list of historical versions of study NCT00611078 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
blood, adipose tissue
Non-Probability Sample
Patients with Soft Tissue Sarcoma at Memorial Sloan Kettering Cancer Center.
Soft Tissue Sarcoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
56
January 2011
January 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:
  • Between 18 and 79 years of age
  • were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma
  • are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)
  • controls will be eligibile for this study if they meet the following criteria
  • are b/w 18-79 years of age
  • have no prior history of cancer (other than non melanoma skin cancer)

Exclusion Criteria:

  • Individuals will be excluded if they
  • are unable to sign informed consent for medical or other reasons
  • do not speak english
Sexes Eligible for Study: All
18 Years to 79 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00611078
04-088
No
Not Provided
Not Provided
Engel, Lawrence Stuart, PhD, Memorial Sloan-Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Not Provided
Principal Investigator: Lawrence Engel, Ph.D. Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
January 2011